2 ASX growth shares with 30% upside: analysts

Could these be bargain buys for growth investors?

| More on:
rising asx share price in food and consumer staples sector represented by happy face made from cut up banana

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you're looking for some ASX growth shares to take your portfolio to the next level, then it could be worth checking out the two listed below.

That's because they have been tipped as buys with price targets offering a potential upside of 30% or greater.

Here's what analysts are tipping from them:

Allkem Ltd (ASX: AKE)

Bell Potter is feeling very bullish on this ASX growth share. In response to the lithium miner's FY 2023 results, the broker put a buy rating and $19.00 price target on its shares. This implies a potential upside of 34% from current levels. It commented:

Big year ahead. AKE reported FY23 underlying EBITDA of US$910m (BP est. US$843m) and NPAT of US$521m (BP est. US$501m). No dividend was declared, as expected. Limited FY24 guidance was provided for AKE's two operating assets: Mt Cattlin spodumene concentrate production at 210-230kt at a unit cost of US$850/dmt; and Olaroz lithium carbonate production of 22-26kt.

ResMed Inc. (ASX: RMD)

Another ASX growth share that could have major upside potential is ResMed. According to a note out of Morgans, its analysts have an add rating and $36.95 price target on the sleep treatment company's shares. This suggests an upside of over 45% for investors.

While a little disappointed with its weaker-than-expected margins in FY 2023, the broker remains positive. It said:

ResMed Inc's 4Q was mixed, as strong sales across all product lines failed to translate into operating leverage.

While softer GPM disappointed, a bit of altruism appears to be at play, as demand fulfillment, despite unfavourable product mix and higher inventory component costs, trumped short-term profit growth. However, we believe an expanding installed base and franchised customers should not be frowned upon by the market, with margins likely to improve through FY24 on abating headwinds.

Motley Fool contributor James Mickleboro has positions in Allkem and ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

a man looks down at his phone with a look of happy surprise on his face as though he is thrilled with good news.
Growth Shares

3 high-quality ASX growth shares to buy in December

Analysts say that these growth shares could be top buys next month.

Read more »

A woman with strawberry blonde hair has a huge smile on her face and fist pumps the air having seen good news on her phone.
Growth Shares

These ASX growth shares can rise 30% to 40%

Analysts believe that big returns could be on the cards for owners of these shares.

Read more »

a happy investor with a wide smile points to a graph that shows an upward trending share price
Growth Shares

Morgans rates these ASX growth shares as strong buys

These growth shares have been given the thumbs up by analysts at Morgans.

Read more »

A man in his 30s holds his laptop and operates it with his other hand as he has a look of pleasant surprise on his face as though he is learning something new or finding hidden value in something on the screen.
Growth Shares

Could buying these ASX shares at $9 now be like investing in Tesla in 2010?

This Melbourne company is making big strides in its field and has returned a phenomenal 67% each year for its…

Read more »

Three people in a corporate office pour over a tablet, ready to invest.
Growth Shares

Lithium, tech, and wine: 3 ASX growth shares to buy

These growth shares tick a lot of boxes for analysts.

Read more »

A woman's hair is blown back and her face is in shock at this big news.
Growth Shares

Analysts say these ASX growth shares can rise 20% to 40%

These could be the growth shares to buy now according to analysts.

Read more »

happy investor, share price rise, increase, up
Growth Shares

If you love ASX growth shares, you'll want to check this new ETF out

Meet the ASX's newest ETF.

Read more »

A young well-dressed couple at a luxury resort celebrate successful life choices.
Growth Shares

ASX growth shares: A once-in-a-lifetime opportunity to get rich?

These ASX shares could be great long term picks for growth investors.

Read more »